COM:KURMAPARTNERS
Minoryx
- Privately Held
locale
Francemarket
PRIVATEindustry
Biotechnologywebsite
kurmapartners.comcrunchbase
minoryx-therapeuticslinkedin
kurma-life-sciences-partners
Minoryx is a biotechnology company focused on the discovery and development of novel therapies for orphan diseases. The company's lead product candidate is leriglitazone (MIN-102), an orally bioavailable, brain-penetrant, small molecule that has been granted orphan drug status for the treatment of X-linked adrenoleukodystrophy (X-ALD).